We serve Chemical Name:2,4,5-Trifluorobenzenesulfonamide CAS:287172-63-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,4,5-Trifluorobenzenesulfonamide
CAS.NO:287172-63-8
Synonyms:2,4,5-trifluorobenzenesulphonamide;2,4,5-trifluorobenzesulfonamide
Molecular Formula:C6H4F3NO2S
Molecular Weight:211.16200
HS Code:2935009090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:305.8ºC at 760 mmHg
Density:1.611g/cm3
Index of Refraction:1.515
PSA:68.54000
Exact Mass:210.99100
LogP:2.53240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2,4,5-trifluorobenzenesulphonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4,5-trifluorobenzesulfonamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4,5-trifluorobenzesulfonamide Use and application,2,4,5-trifluorobenzesulfonamide technical grade,usp/ep/jp grade.
Related News: Since it emerged as a shareholder of GSK in April, Elliott has reportedly been trying to gin up investor support to move Walmsley to the consumer health spinoff rather than to let her lead the new GSK after the separation. 2-(but-3′-enylthio)benzonitrile manufacturers Lonza’s Nansha site is fully integrated within the company’s global manufacturing network. Scientists and engineers based in Nansha focus on API development and manufacturing for customers around the globe. (24,34,44-pentaoxolane-2,3,4-triylidene)tris(34,44,54-heptaoxidane-3,5-dione) suppliers Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 1-(2-(4-chlorophenyl)-5-(4-fluorophenoxy)-2-methoxypentyl)-1H-1,2,4-triazole vendor & factory GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. ,Since it emerged as a shareholder of GSK in April, Elliott has reportedly been trying to gin up investor support to move Walmsley to the consumer health spinoff rather than to let her lead the new GSK after the separation.
